Their effectiveness is a testament to the progress in pharmaceutical development, offering patients improved management options and the potential for a better quality of life
Specifically, excessive activation of NRF2 may promote cell proliferation and tumorigenesis, highlighting the need for a comprehensive assessment of safety and side effects before clinical application
Additionally, Mihir Taneja has not been associated with Belcher/BPI as an employee, owner or officer for over five years. Before his sentencing, Taneja was the CEO of a health care firm called GeoPharma Inc., which traded under the ticker GORX and was then the parent company of Belcher
This can cause learning problems or intellectual disabilities
Affiliate Disclosure: Some links in this article may be affiliate links, meaning the publisher could earn a small commission if a reader purchases a product through these links, at no extra cost to the reader